Engrossed
Underlined text would be added to current law. Struck-through text would be removed.
| By: Menéndez, Alvarado | S.B. No. 1525 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to prior authorization for prescription drug benefits | |
| related to the treatment of neurodegenerative diseases. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. The heading to Subchapter N, Chapter 1369, | |
| Insurance Code, is amended to read as follows: | |
| SUBCHAPTER N. COVERAGE OF PRESCRIPTION DRUGS FOR AUTOIMMUNE AND | |
| NEURODEGENERATIVE DISEASES AND CERTAIN BLOOD DISORDERS | |
| SECTION 2. Section 1369.654, Insurance Code, is amended by | |
| amending Subsection (a) and adding Subsection (c) to read as | |
| follows: | |
| (a) A health benefit plan issuer that provides prescription | |
| drug benefits may not require an enrollee to receive more than one | |
| prior authorization annually of the prescription drug benefit for a | |
| prescription drug prescribed to treat an autoimmune disease, a | |
| neurodegenerative disease, hemophilia, or Von Willebrand disease. | |
| (c) Notwithstanding Subsection (a), a health benefit plan | |
| issuer may require an enrollee who is prescribed a new prescription | |
| drug to treat a neurodegenerative disease to obtain a prior | |
| authorization for the prescription drug. | |
| SECTION 3. The change in law made by this Act applies only | |
| to a health benefit plan that is delivered, issued for delivery, or | |
| renewed on or after January 1, 2026. A health benefit plan | |
| delivered, issued for delivery, or renewed before January 1, 2026, | |
| is governed by the law as it existed immediately before the | |
| effective date of this Act, and that law is continued in effect for | |
| that purpose. | |
| SECTION 4. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.